|
FY2026
12 months to Apr 30, 2026
|
FY2025
12 months to Apr 30, 2025
|
FY2024
12 months to Apr 30, 2024
|
FY2023
12 months to Apr 30, 2023
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of sales | ||||
| Gross margin | ||||
| Operating expenses: | ||||
| Research and development | ||||
| Selling, general and administrative | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Other income (expense) | ||||
| Interest expense | ||||
| Other income | ||||
| Total other expense | ||||
| Net loss | ||||
| Net loss per share, basic and diluted (in dollars per share) | ||||
| Weighted average common shares outstanding, basic and diluted (in shares) |
Loading...
